Dr. Stuart Harvey Kuschner, MD

Dr. Kuschner practices at Tower Outpatient Surgery Center in Los Angeles, California.

Dr. Kuschner's NPI, 1275577892, was assigned on June 15, 2006. Dr. Kuschner graduated from New York University School of Medicine in 1981. Dr. Kuschner holds California license G58710.

Dr. Kuschner's primary practice is Tower Outpatient Surgery Center, at 8635 W 3rd St, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 659-9408.

Dr. Kuschner's primary practice is Tower Outpatient Surgery Center in Los Angeles, California. Dr. Kuschner is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kuschner practices. Vendor and product names are available with a free account.

Hand surgery is Dr. Kuschner's primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Kuschner is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Kuschner's licenses on file in 2 states: California and New York.

Dmand AI lists arm, wrist, hand fracture and dislocation, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation, joint cyst and minor injury to a limb among the conditions Dr. Kuschner treats.

CMS data shows 3,089 Medicare services from Dr. Kuschner across 18 procedure codes in 2024, for 730 Medicare patients. Medicare paid $154,497 for them.

CMS counts 730 Medicare patients who saw Dr. Kuschner in 2024. The largest group is 65 to 74, with 313 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kuschner's median patient age at 67, with 58% women.

In 2024, Dr. Kuschner wrote 32 Medicare Part D claims for 29 patients. 100% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $214 in total drug cost. In 2022, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kuschner for performance year 2024, reported as part of a group. Dr. Kuschner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kuschner as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 42 papers to Dr. Kuschner, published from 2015 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Radiography, Postoperative Complications and Carpal Tunnel Syndrome. Dr. Kuschner has published most often in J Hand Surg Am. Dr. Kuschner's most frequent co-authors are Harris Gellman, MD, William W. Brien, MD and Harin Bhavin Parikh, MD.

CMS Open Payments shows 49 general payments to Dr. Kuschner from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Endo Pharmaceuticals Inc. paid the most, $760.

Dmand AI lists 1 award for Dr. Kuschner, most recently CMS Stage 1 EHR in 2013.

Dr. Kuschner graduated from New York University School of Medicine in 1981.

Dr. Kuschner is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.